Does LEUPROLIDE Cause Prostate cancer? 1,736 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,736 reports of Prostate cancer have been filed in association with LEUPROLIDE (Fensolvi). This represents 2.5% of all adverse event reports for LEUPROLIDE.
1,736
Reports of Prostate cancer with LEUPROLIDE
2.5%
of all LEUPROLIDE reports
836
Deaths
306
Hospitalizations
How Dangerous Is Prostate cancer From LEUPROLIDE?
Of the 1,736 reports, 836 (48.2%) resulted in death, 306 (17.6%) required hospitalization, and 23 (1.3%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
Yes, Prostate cancer is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
RITUXIMAB (317)
Which LEUPROLIDE Alternatives Have Lower Prostate cancer Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM